Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$244M |
| 2 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$143M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$137M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$109M |
| 5 |
VMW
VMware, Inc
VMW
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Apple
AAPL
|
+$763M |
| 3 |
Microsoft
MSFT
|
+$618M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$592M |
| 5 |
AABA
Altaba Inc
AABA
|
+$393M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.41% |
| 2 | Healthcare | 5.88% |
| 3 | Financials | 5.51% |
| 4 | Consumer Discretionary | 4.79% |
| 5 | Communication Services | 4.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITIC
6076
Investors Title Co
ITIC
$546M
| $20K | ﹤0.01% |
108
-180
| -63% | -$34.3K |
|
6077
Seres Therapeutics
MCRB
$46.8M
| $20K | ﹤0.01% |
115
-264
| -70% | -$43.1K |
|
6078
Nathan's Famous
NATH
$402M
| $20K | ﹤0.01% |
210
-385
| -65% | -$32K |
|
6079
Minerva Neurosciences
NERV
$185M
| $20K | ﹤0.01% |
289
-491
| -63% | -$29.8K |
|
6080
Oragenics
OGEN
$2.26M
| $20K | ﹤0.01% |
8
+7
| +700% | +$18.4K |
|
6081
PUT
Omeros
OMER
$857M
| $20K | ﹤0.01% |
1,100
-700
| -39% | -$12.1K |
|
6082
Preformed Line Products
PLPC
$1.75B
| $20K | ﹤0.01% |
224
-513
| -70% | -$38.1K |
|
6083
Simulations Plus
SLP
$369M
| $20K | ﹤0.01% |
868
-1,412
| -62% | -$26.7K |
|
6084
Sonida Senior Living
SNDA
$1.91B
| $20K | ﹤0.01% |
123
-319
| -72% | -$52.6K |
|
6085
SoundThinking
SSTI
$100M
| $20K | ﹤0.01% |
530
-7,370
| -93% | -$237K |
|
6086
CALL
Titan Machinery
TITN
$396M
| $20K | ﹤0.01% |
1,300
-1,000
| -43% | -$19.4K |
|
|
PVLA
6087
Palvella Therapeutics
PVLA
$1.99B
| $20K | ﹤0.01% |
48
-325
| -87% | -$155K |
|
|
PETQ
6088
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $20K | ﹤0.01% |
748
-985
| -57% | -$21.4K |
|
|
CVLY
6089
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $20K | ﹤0.01% |
699
-1,259
| -64% | -$33.6K |
|
|
SRGA
6090
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $20K | ﹤0.01% |
140
+139
| +13,900% | +$19.1K |
|
|
PBCT
6091
CALL
DELISTED
People's United Financial Inc
PBCT
| $20K | ﹤0.01% |
1,100
+1,000
| +1,000% | +$18.6K |
|
|
TLGT
6092
DELISTED
Teligent, Inc
TLGT
| $20K | ﹤0.01% |
592
-328
| -36% | -$10.3K |
|
6093
Arbutus Biopharma
ABUS
$857M
| $19K | ﹤0.01% |
2,592
+2,460
| +1,864% | +$14.6K |
|
6094
BayCom
BCML
$329M
| $19K | ﹤0.01% |
+751
| New | +$18K |
|
6095
CALL
Invesco DB Base Metals Fund
DBB
$312M
| $19K | ﹤0.01% |
1,100
+700
| +175% | +$13.1K |
|
6096
Daily Journal
DJCO
$809M
| $19K | ﹤0.01% |
81
-155
| -66% | -$35.5K |
|
6097
Denali Therapeutics
DNLI
$3.65B
| $19K | ﹤0.01% |
1,238
-2,099
| -63% | -$39.6K |
|
6098
Fidus Investment
FDUS
$749M
| $19K | ﹤0.01% |
+1,338
| New | +$18.3K |
|
6099
PUT
Flowers Foods
FLO
$1.49B
| $19K | ﹤0.01% |
900
+800
| +800% | +$17.1K |
|
6100
PUT
Flotek Industries
FTK
$852M
| $19K | ﹤0.01% |
983
+750
| +322% | +$18.6K |
|
Similar funds
Barclays's Q2 2018 Portfolio in Review
As of Q2 2018, Barclays held 7,691 positions worth $116B, down 11% from $131B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays withdrew a net $18.4B in Q2 2018, closing 585 positions and reducing 3,614 holdings. Its most notable exit was Time Warner Inc, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 8.6% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in Evergy worth $42M.
- Barclays's largest Q2 2018 buy was Evergy: 747,502 shares worth $42M.
- Barclays added most to State Street Industrial Select Sector SPDR ETF in Q2 2018, an estimated $244M increase.
- Barclays's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- Barclays fully exited Time Warner Inc in Q2 2018, selling an estimated $290M.
- Barclays's ten largest holdings make up 27% of its $116B portfolio in Q2 2018.
- Barclays opened 402 new positions and closed 585 in Q2 2018.
- Barclays's portfolio value fell 11% quarter-over-quarter to $116B.
Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.